Karimi, Y., Hutchings, M., Phillips, T. J., Trneny, M., Dickinson, M., Offner, F. C., Morschhauser, F., Bachy, E., Bartlett, N. L., Brody, J., Zaucha, J., Wróbel, T., Gil, L., Breton, V., Negricea, R., Kallemeijn, M., Berthier, A., Sellam, G., Lundberg, L., Carlo-Stella, C. (2026). Fixed-duration glofitamab monotherapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL) with/without prior Bruton's tyrosine kinase inhibitor (BTKi) exposure: Updated data after a 3.5-year follow-up.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7006